Nedaei K, Hesaraki M, Mazloomzadeh S, Totonchi M, Biglari A R. Lentiviral Mediated Expression of Soluble Neuropilin 1 Inhibits Semaphorin 3A-mediated Collapse Activity in Vitro. BCN 2021; 12 (2) :223-232
URL:
http://bcn.iums.ac.ir/article-1-1405-en.html
1- Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
2- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
3- Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
4- Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Abstract:
Introduction: Semaphorin 3A (Sema 3A) is a secreted protein, which plays an integral part in developing the nervous system. It has collapse activity on the growth cone of dorsal root ganglia. After the development of the nervous system, Sema 3A expression decreases. Neuropilin 1 is a membrane receptor of Sema 3A. When semaphorin binds to neuropilin 1, the recruitment of oligodendrocyte precursor cells to the demyelinated site decreases. In Multiple Sclerosis (MS), Sema 3A expression increases and inhibits oligodendrocyte precursor cell differentiation. Therefore, the remyelination of axons gets impaired. We hypothesized that the function of Sema 3A could be inhibited by neutralizing its binding to membrane NRP1.
Methods: we cloned a soluble form of mouse Neuropilin 1 (msNRP1) in a lentiviral vector and expressed the recombinant protein in HEK293T cells. Then, the conditioned medium of the transduced cells was used to evaluate the effects of the msNRP1 on the inhibition of Sema 3A-induced growth cone collapse activity. Dorsal root ganglion explants of timed pregnant (E13) mice were prepared. Then, the growth cone collapse activity of Sema 3A was assessed in the presence and absence of msNRP1-containing conditioned media of transduced and non-transduced HEK293T cells. Comparisons between groups were performed by 1-way ANOVA and post hoc Tukey tests.
Results: msNRP1 was successfully cloned and transduced in HEK293T cells. The supernatant of transduced cells was concentrated and evaluated for the production of msNRP1. ELISA results indicated that transduced cells secreted msNRP1. Growth cone collapse assay showed that Sema 3A activity was significantly reduced in the presence of the conditioned medium of msNRP1-transduced HEK293T cells. Conversely, a conditioned medium of non-transduced HEK293T cells could not effectively prevent Sema 3A growth cone collapse activity.
Conclusion: Our results indicated that msNRP1 was successfully produced in HEK293T cells. The secreted msNRP1 effectively prevented Sema 3A collapse activity. Therefore, msNRP1 can increase remyelination in MS lesions, although more studies using animal models are required.
Full-Text [PDF 3175 kb]
| |
Full-Text (HTML)
Highlights
● A soluble form of mouse Neuropilin1 (msNRP1) was cloned in a lentiviral vector.
● msNRP1 was successfully secreted by the transduced HEK293T in the supernatant.
● msNRP1-containing supernatant inhibited growth cone collapse activity of semaphorins 3A.
Plain Language Summary
Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system. In MS, axons of neuronal cells become demyelinated, and the remyelination process is also defective. Oligodendrocyte precursor cells must survive, proliferate, and migrate towards demyelinated neurons and differentiate into mature oligodendrocytes to produce myelin and repair the neurons. Semaphorin 3A (Sema 3A) is a molecule that reduces the remyelination by preventing oligodendrocyte precursor cells from proliferating, migrating towards lesions, and differentiating into mature oligodendrocytes. We successfully produced mouse soluble Neuropilin 1 (msNRP1) that can bind Sema 3A and inhibit its activity. In other words, the msNRP1 was used to inhibit the activity of Sema 3A. Neural cells of dorsal root ganglia were cultured in the presence of Sema 3A with and without msNRP1. We observed that when msNRP1 was added to the neuronal cells culture, the growth cones could form. On the other hand, the growth cones collapsed when msNRP1 was not added to the cultures. This finding is promising in outcome of MS treatment. Remyelination is defective in MS patients, and axons are progressively demyelinated. Finding a molecule that can prevent demyelination and enhance remyelination will be of great importance for MS treatment and improvement of their condition.
Type of Study:
Original |
Subject:
Cellular and molecular Neuroscience Received: 2020/01/15 | Accepted: 2020/08/2 | Published: 2021/03/1